21 Mar 2017

Medical Delta Café From “Bench to Bin”?

Batavia Biosciences, Zernikedreef 16, 2333 CL Leiden

March 21, 2017
02:30 PM Start time - 07:00 PM End time
Sign up for this event

The landscape of translational research

The ability to translate biopharmaceutical research into product success has a high failure rate globally. The sad experience is that up to 75% of the published preclinical data cannot be validated to the point of which the project could be continued (Begley & Ellis, Drug Development: Raise standards for preclinical cancer research, 2012, Nature 483, 531-533).

During the event we intend to discuss important aspects linked to the high failure rate and provide potential solutions:

  • What are the main contributors to such high failure rates?
  • How can the robustness of published preclinical research be increased?
  • How is research in The Netherlands positioned in this respect?
  • How can we improve the translational success rate?
  • How can different players in the field contribute to the product development chain

These questions will be addressed from different angles by pitches from the industry, academia, technology transfer offices and funders.


14.30 - 15.00

Registration / Coffee

15.00 - 15.10

Welcome and introduction theme of the day
Colja Laane, Medical Delta

15.10 - 15.45

Keynote - A tale of two viruses: HIV and Zika
Dan Barouch
Harvard University, United States

15.45 - 16.00

From fundamental to preclinical research: Stem cell-based gene therapy
Frank Staal, LUMC

16.00 - 16.15

Role and wishes of TTOs in translational research
Ivo de Nooijer, LURIS

16.15 - 16.30


16.30 - 16.45

View from the Dutch pharma branch organization
Peter Bertens, Vereniging Innovatieve geneesmiddelen

16.45 - 17.00

Funding possibilities of translational research
Ineke Slaper, ZonMW

17.00 - 17.15

View from a VC
Edward van Wezel, BioGeneration Ventures

17.15 - 17.30

The importance of tests and bio-analysis in clinical development
Ruud Santing, Eurofins

17.30 - 18.00

Ensuring a smooth transition from bench to clinic
Menzo Havenga, Batavia Biosciences

18.00 - 18.15

Discussion and conclusions
moderator Colja Laane, Medical Delta

18.15 - 19.00

Drinks & Bites